A Prescription Audit of Inpatient Department of Super Speciality Hospital in National Capital Region of India

Sponsor
Kakatiya University (Other)
Overall Status
Completed
CT.gov ID
NCT05894278
Collaborator
Fortis Hospital, India (Other)
300
1
2.9
103.8

Study Details

Study Description

Brief Summary

Prescription auditing is the art to check the detailing, compatibility and performance of the generated prescription from the physician to the pharmacist and patient, by means of the WHO checklist for prescription auditing. An audit is defined as the review and evaluation of the healthcare procedures and documentation to compare the quality of care provided, with accepted standards.

In this study, we will collect In-patient prescriptions from Fortis Hospital. And it will be evaluated for 13 list out parameters i.e Hospital unique ID, patient name, age, sex, weight, date of consultation, cleanliness and legibility, brief history, allergies, clinical examination, presumptive or definite diagnosis, medicine prescribed by generic name, dose, duration, history of a previous adverse event, appropriate abbreviations used, drug-drug interaction, drug duplication, doctor name, registration number and signature. The study is analyzed by Statistical Process Control (SPC).

Condition or Disease Intervention/Treatment Phase
  • Other: Prescription data collection

Detailed Description

Aim of the study:

The aim of the study is to evaluate the quality of the prescription provided to the inpatient.

Objectives of the study:

To study the quality of good prescription In minimization of prescription errors and medication errors Also to comply with good clinical practice Enhancement of patient safety In the maintenance of rational prescribing To study the quality of care provided by the hospital to the patient

Plan of study:

To select the patient based on inclusion and exclusion criteria To collect the information from IP prescription and drug chart To identify prescribing errors and medication error To study the management of good prescription

Methodology:

Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)

Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)

Subject Eligibility:
  1. Inclusion Criteria Participants who are willing to participate Participants who are admitted in the in-patient department Participants admitted during the study period Participants who have a prescription which is legible and complete

  2. Exclusion Criteria Participants who are unwilling to provide the required information Participants who are not admitted the in-patient department Participants whose prescription is not legible and competent

  3. Source of the data: Review of In-patient prescription

Sample Size:

300 prescriptions

Study Design

Study Type:
Observational
Actual Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prescription Audit of Inpatient Department of National Accreditation Board for Hospitals and Healthcare Providers Approved Super Speciality Hospital in National Capital Region of India
Actual Study Start Date :
Mar 1, 2023
Actual Primary Completion Date :
May 28, 2023
Actual Study Completion Date :
May 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Compliance

Prescription properly filled for specific parameters

Other: Prescription data collection
Prescription data collection

Non Compliance

Prescription is not filled with specific parameters

Other: Prescription data collection
Prescription data collection

Not available - NA

Prescription does not contain specific data

Other: Prescription data collection
Prescription data collection

Outcome Measures

Primary Outcome Measures

  1. Percentage prescription [March 2023 and May 2023]

    Prescription filled for specific parameter

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants who are willing to participate

  • Participants who are admitted in the in-patient department

  • Participants admitted during the study period

  • Participants who have a prescription which is legible and complete

Exclusion Criteria:
  • Participants who are unwilling to provide the required information

  • Participants who are not admitted the in-patient department

  • Participants whose prescription is not legible and competent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fortis Hospital Noida Uttar Pradesh India 201301

Sponsors and Collaborators

  • Kakatiya University
  • Fortis Hospital, India

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Satyam Suman, Department of Clinical Pharmacy and Clinical Pharmacology, Kakatiya University
ClinicalTrials.gov Identifier:
NCT05894278
Other Study ID Numbers:
  • FORTIS/IEC/2023/MAR/PA02
First Posted:
Jun 8, 2023
Last Update Posted:
Jun 8, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 8, 2023